Vimarsana
Biggest News Aggregation in the World

John Jack Kessler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Jack Kessler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Jack Kessler Today - Breaking & Trending Today

Third-Generation Ohio Farm to Sell Land for Intel's Microchip Plants - Vimarsana News

Third-Generation Ohio Farm to Sell Land for Intel's Microchip Plants

New Albany a city in rural Ohio is set to become home to the largest private investment in ...

Results from phase 3 gene therapy trial for diabetic peripheral neuropathy published online by Clinical and Translational Science - Vimarsana News

Results from phase 3 gene therapy trial for diabetic peripheral neuropathy published online by Clinical and Translational Science

Results from phase 3 gene therapy trial for diabetic peripheral neuropathy published online by Clinical and Translational Science Share Article VM202 (donaperminogene seltoplasmid) is a first-in-class, proprietary, non-viral, potentially regenerative plasmid DNA gene therapy. The Phase 3 study for painful DPN, led by Professor John (Jack) Kessler at Northwestern University, was conducted in two parts, one for 9 months (VMDN-003; 500 subjects) and one with a 3-month extension to 12 months (VMDN-003b; 101 subjects). This is the first gene therapy phase 3 trial that has ever been done for pain....

Source: prweb.com